Nature-Inspired Strategies in Cancer Management: The Potential of Plant Extracts in Modulating Tumour Biology

Marcin Hołota1, Małgorzata M Posmyk1

  • 1Department of Plant Ecophysiology, Faculty of Biology and Environmental Protection, University of Lodz, Banacha 12/16, 90-237 Lodz, Poland.

Insights

Plant extracts offer promising anticancer properties, acting through various mechanisms to combat cancer and reduce chemotherapy side effects. Further research is needed to integrate these natural compounds into cancer therapy safely and effectively.

Area of Science:

  • Oncology
  • Pharmacology
  • Phytochemistry

Background:

  • Cancer remains a leading global cause of death with significant unmet needs in treatment.
  • Conventional cancer therapies often have limitations, including incomplete eradication of cancer cells and severe side effects.
  • There is a growing interest in natural compounds, particularly phytochemicals from plant extracts, as potential therapeutic agents.

Purpose of the Study:

  • To review plant extracts with demonstrated anticancer properties.
  • To explore the diverse mechanisms of action of these plant extracts, including proapoptotic, antiproliferative, antiangiogenic, and immunomodulatory effects.
  • To discuss the potential of plant extracts in mitigating chemotherapy side effects and their future prospects in cancer treatment.

Main Methods:

  • Literature review of scientific articles on plant extracts and their anticancer activities.
  • Analysis of studies detailing the mechanisms of action of phytochemicals.
  • Examination of research on the supportive role of plant extracts in cancer therapy and side effect management.

Main Results:

  • Numerous plant extracts exhibit significant anticancer properties through various biological pathways.
  • Certain plant-derived compounds show efficacy in reducing the adverse effects associated with chemotherapy.
  • The review highlights the potential of plant extracts as complementary agents in cancer treatment strategies.

Conclusions:

  • Plant extracts represent a valuable resource for developing novel anticancer strategies and supportive care.
  • Further research is essential to address challenges related to safety, quality, purity, and precise dosing for clinical application.
  • Integrating phytochemicals into cancer therapy could enhance treatment outcomes and patient quality of life, necessitating a balanced approach between natural medicine and conventional standards.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
662
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.9K
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.8K